LISA KRINEY: Open Payments
NPI 1669432308 · DOYLESTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 23 payments from 12 companies in 2025. Trend: 2023 $1,784 · 2024 $1,724 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $133 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $74 |
| Janssen Biotech, Inc. | 2 | $55 |
| Lilly USA, LLC | 2 | $41 |
| Braintree Laboratories, Inc. | 1 | $31 |
| Medtronic, Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
Products named: XIFAXAN, RINVOQ, TREMFYA, DUPIXENT, OMVOH, MAVYRET, SKYRIZI, SUFLAVE.
Industry payments across PA — which companies pay providers there.
